Sleep and breathing in high altitude pulmonary edema susceptible subjects at 4,559 meters

Sleep

Volumn 35, Issue 10, 2012, Pages 1413-1421

  Nussbaumer Ochsner, Yvonne ^a,b   Schuepfer, Nicole ^c   Ursprung, Justyna ^a,b   Siebenmann, Christoph ^c   Maggiorini, Marco ^a,b   Bloch, Konrad E ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c ETH ZURICH   (Switzerland)

Author keywords

Control of breathing; Dexamethasone; High altitude illness; Hypoxia; Sleep apnea

Indexed keywords

DEXAMETHASONE; PLACEBO;

ADULT; ALTITUDE DISEASE; APNEA HYPOPNEA INDEX; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH ALTITUDE DEVELOP PULMONARY EDEMA; HUMAN; HYPOXEMIA; LUNG EDEMA; MALE; META ANALYSIS; OXYGEN SATURATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SLOW WAVE SLEEP;

ADULT; ALTITUDE; ALTITUDE SICKNESS; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DISEASE SUSCEPTIBILITY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PULMONARY EDEMA; QUESTIONNAIRES; RESPIRATION; SLEEP;

EID: 84867068652     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.2126     Document Type: Article

References (34)

1. Maggiorini M, Buhler B, Walter M, Oelz O. Prevalence of acute mountain sickness in the Swiss Alps. BMJ 1990;301:853-5. (Pubitemid 20342788)
2. Forwand SA, Landowne M, Follansbee JN, Hansen JE. Effect of acetazolamide on acute mountain sickness. N Engl J Med 1968;279:839-45.
3. Greene MK, Kerr AM, McIntosh IB, Prescott RJ. Acetazolamide in prevention of acute mountain sickness: a double-blind controlled cross-over study. Br Med J (Clin Res Ed) 1981;283:811-3. (Pubitemid 11000266)
4. Johnson TS, Rock PB, Fulco CS, Trad LA, Spark RF, Maher JT. Prevention of acute mountain sickness by dexamethasone. N Engl J Med 1984;310:683-6. (Pubitemid 14164643)
5. Ellsworth AJ, Larson EB, Strickland D. A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis. Am J Med 1987;83:1024-30. (Pubitemid 18098873)
6. Maggiorini M, Melot C, Pierre S, et al. High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 2001;103:2078-83. (Pubitemid 32373011)
7. Bartsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med 1991;325:1284-9.
8. Maggiorini M, Brunner-La Rocca HP, Peth S, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med 2006;145:497-506.
9. Nussbaumer-Ochsner Y, Ursprung J, Siebenmann C, Maggiorini M, Bloch KE. Effect of short-term acclimatization to high altitude on sleep and nocturnal breathing. Sleep 2012;35:419-23.
10. Dehnert C, Grünig E, Mereles D, von Lennep N, Bärtsch P. Identification of individuals susceptible to high-altitude pulmonary oedema at low altitude. Eur Respir J 2005;25:545-51. (Pubitemid 40331187)
11. Hackett PH, Roach RC, Schoene RB, Harrison GL, Mills WJ Jr. Abnormal control of ventilation in high-altitude pulmonary edema. J Appl Physiol 1988;64:1268-72. (Pubitemid 18088552)
12. Fehm HL, Bieber K, Benkowitsch R, Fehm-Wolfsdorf G, Voigt KH, Born J. Relationships between sleep stages and plasma cortisol: a single case study. Acta Endocrinol (Copenh) 1986;111:264-70. (Pubitemid 16160973)
13. Born J, DeKloet ER, Wenz H, Kern W, Fehm HL. Gluco- and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors. Am J Physiol 1991;260:E183-E188.
14. Bloch KE, Latshang TD, Turk AJ, et al. Nocturnal periodic breathing during acclimatization at very high altitude at Mount Muztagh Ata (7,546 m). Am J Respir Crit Care Med 2010;182:562-8.
15. Nussbaumer-Ochsner Y, Schuepfer N, Siebenmann C, Maggiorini M, Bloch KE. High altitude sleep disturbances monitored by actigraphy and polysomnography. High Alt Med Biol 2011;12:229-36.
16. Sackner MA, Watson H, Belsito AS, et al. Calibration of respiratory inductive plethysmograph during natural breathing. J Appl Physiol 1989;66:410-20. (Pubitemid 19056107)
17. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington, DC: Public Health Service, US Government Printing Office; 1968.
18. Nussbaumer-Ochsner Y, Latshang TD, Ulrich S, Kohler M, Thurnheer R, Bloch KE. Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn. A randomized, placebo-controlled, double-blind trial. Chest 2012;141:131-8.
19. Kohler M, Kriemler S, Wilhelm EM, Brunner-Larocca H, Zehnder M, Bloch KE. Children at high altitude have less nocturnal periodic breathing than adults. Eur Respir J 2008;32:189-97.
20. Parrott AC, Hindmarch I. Factor analysis of a sleep evaluation questionnaire. Psychol Med 1978;8:325-9. (Pubitemid 8324649)
21. Tarrasch R, Laudon M, Zisapel N. Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients. Hum Psychopharmacol 2003;18:603-10. (Pubitemid 38035077)
22. Maggiorini M, Muller A, Hofstetter D, Bartsch P, Oelz O. Assessment of acute mountain sickness by different score protocols in the Swiss Alps. Aviat Space Environ Med 1998;69:1186-92. (Pubitemid 28544217)
23. Jafarian S, Gorouhi F, Taghva A, Lotfi J. High-altitude sleep disturbance: results of the Groningen Sleep Quality Questionnaire survey. Sleep Med 2008;9:446-9. (Pubitemid 351664087)
24. Johnson PL, Edwards N, Burgess KR, Sullivan CE. Sleep architecture changes during a trek from 1400 to 5000 m in the Nepal Himalaya. J Sleep Res 2010;19:148-56.
25. Mizuno K, Asano K, Okudaira N. Sleep and respiration under acute hypobaric hypoxia. Jpn J Physiol 1993;43:161-75.
26. Nicholson AN, Smith PA, Stone BM, Bradwell AR, Coote JH. Altitude insomnia: studies during an expedition to the Himalayas. Sleep 1988;11:354-61.
27. Beaumont M, Goldenberg F, Lejeune D, Marotte H, Harf A, Lofaso F. Effect of zolpidem on sleep and ventilatory patterns at simulated altitude of 4,000 meters. Am J Respir Crit Care Med 1996;153:1864-9. (Pubitemid 26187912)
28. Eichenberger U, Weiss E, Riemann D, Oelz O, Bartsch P. Nocturnal periodic breathing and the development of acute high altitude illness. Am J Respir Crit Care Med 1996;154:1748-54. (Pubitemid 26424945)
29. Xie A, Skatrud JB, Puleo DS, Rahko PS, Dempsey JA. Apnea-hypopnea threshold for CO2 in patients with congestive heart failure. Am J Respir Crit Care Med 2002;165:1245-50. (Pubitemid 34461734)
30. Duplain H, Vollenweider L, Delabays A, Nicod P, Bartsch P, Scherrer U. Augmented sympathetic activation during short-term hypoxia and high-altitude exposure in subjects susceptible to high-altitude pulmonary edema. Circulation 1999;99:1713-8. (Pubitemid 29162484)
31. Scherrer U, Vollenweider P, Randin D, Jequier E, Nicod P, Tappy L. Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation 1993;88:388-94. (Pubitemid 23228037)
32. Dumont L, Mardirosoff C, Tramer MR. Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ 2000;321:267-72. (Pubitemid 30487464)
33. Hackett PH, Roach RC, Wood RA, et al. Dexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med 1988;59:950-4.
34. Clarenbach CF, Senn O, Christ AL, Fischler M, Maggiorini M, Bloch KE. Lung function and breathing pattern in subjects developing high altitude pulmonary edema. PLoS One 2012;7:e41188.